Christos S Karapetis

Christos S Karapetis

UNVERIFIED PROFILE

Are you Christos S Karapetis?   Register this Author

Register author
Christos S Karapetis

Christos S Karapetis

Publications by authors named "Christos S Karapetis"

Are you Christos S Karapetis?   Register this Author

81Publications

2240Reads

22Profile Views

Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab.

Target Oncol 2019 12;14(6):743-748

College of Medicine and Public Health, Flinders University, Adelaide, SA, 5042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-019-00683-zDOI Listing
December 2019

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer.

Front Genet 2019 21;10:1118. Epub 2019 Nov 21.

Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2019.01118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881479PMC
November 2019

Response to the Letter to the Editor: Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC.

J Thorac Oncol 2019 Sep 7;14(9):e208. Epub 2019 Jun 7.

College of Medicine and Public Health, Flinders University, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.035DOI Listing
September 2019

Author's Reply.

J Thorac Oncol 2019 Sep;14(9):e210

College of Medicine and Public Health, Flinders University, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.07.009DOI Listing
September 2019

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials.

J Thorac Oncol 2019 08 15;14(8):1440-1446. Epub 2019 Apr 15.

College of Medicine and Public Health, Flinders University, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.04.006DOI Listing
August 2019

First-line therapy for metastatic colorectal cancer: Current perspectives and future directions.

Asia Pac J Clin Oncol 2019 Feb;15 Suppl 1:3-14

Department of Cancer Care Services, Royal Brisbane Hospital, University Of Queensland, Herston, Queensland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ajco.13119
Publisher Site
http://dx.doi.org/10.1111/ajco.13119DOI Listing
February 2019

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

N Engl J Med 2018 12 25;379(24):2342-2350. Epub 2018 Sep 25.

From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), Florida Cancer Specialists, Fleming Island (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida; Tennessee Oncology, Chattanooga (D.D.), and Sarah Cannon Research Institute, Nashville (D.D., D.R.S.) - both in Tennessee; Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, CiberOnc, Universidad Complutense and Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain; Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.K.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan; Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Adelaide, SA (C.S.K.) - all in Australia; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea; Vivantes Klinikum Neukoelln, Berlin (M.W.), and the Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.) - both in Germany; Centre Hospitalier Universitaire de Liège, Liège (M.B.), and University Hospitals KU Leuven, Leuven (J.V.) - both in Belgium; Centre Hospitalier Universitaire de Montpellier and Institut du Cancer de Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-site René Gauducheau, Saint Herblain (S.H.) - all in France; National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.); the University of Manchester and the Christie NHS Foundation Trust, Manchester (C.F.-F.), AstraZeneca, Alderley Park (C.W.), and AstraZeneca, Cambridge (M.T.) - all in the United Kingdom; AstraZeneca, Gaithersburg, MD (G.M., P.A.D.); and Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1809697DOI Listing
December 2018

Author reply.

Intern Med J 2018 11;48(11):1415-1416

Medical Oncology, Flinders Medical Centre, and Flinders University, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.14095DOI Listing
November 2018

A mixed methods analysis of experiences and expectations among early-career medical oncologists in Australia.

Asia Pac J Clin Oncol 2018 Oct 26;14(5):e521-e527. Epub 2018 Jan 26.

Department of Medical Oncology, Royal Brisbane and Women's Hospital, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12844DOI Listing
October 2018

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials.

Cancers (Basel) 2018 Oct 15;10(10). Epub 2018 Oct 15.

College of Medicine and Public Health, Flinders University, Adelaide 5042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10100384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210178PMC
October 2018

The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology.

Semin Oncol 2018 10 24;45(5-6):284-290. Epub 2018 Oct 24.

Royal Hobart Hospital, Hobart, Tasmania, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2018.06.004DOI Listing
October 2018

Response to: "Consideration of KRAS Mutation Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET, in Patients With Colorectal Liver Metastases".

Ann Surg 2018 07;268(1):e9-e10

Department of Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia. Department of Medical Oncology, Flinders Cancer for Innovation in Cancer, Adelaide, South Australia, Australia Department of Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia Department of Surgery, Flinders Medical Centre & Flinders University, Adelaide, South Australia, Australia Department of Medical Oncology, Flinders Medical Centre & Flinders University, Adelaide, South Australia, Australia Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia Department of Surgery, Flinders Medical Centre & Flinders University, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000002266DOI Listing
July 2018

Medical Oncology Group of Australia position statement and membership survey on voluntary assisted dying.

Intern Med J 2018 07;48(7):774-779

University of South Australia Cancer Research Institute, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13951DOI Listing
July 2018

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers.

Front Oncol 2018 24;8:275. Epub 2018 Jul 24.

Flinders Centre for Innovation in Cancer, College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066577PMC
July 2018

Acanthosis Palmaris: A Rare Paraneoplastic Manifestation of Non-Small-Cell Lung Cancer.

J Oncol Pract 2018 05 22;14(5):331-332. Epub 2018 Jan 22.

Flinders Centre for Innovation in Cancer, Flinders Medical Centre; and Flinders University, Bedford Park, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.028746DOI Listing
May 2018

Localised prostate cancer in elderly men aged 80-89 years, findings from a population-based registry.

BJU Int 2018 05;121 Suppl 3:48-54

Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14228DOI Listing
May 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

N Engl J Med 2017 11 8;377(20):1919-1929. Epub 2017 Sep 8.

From the H. Lee Moffitt Cancer Center and Research Institute, Tampa (S.J.A., A.C., J.E.G.), Cancer Specialists of North Florida, Jacksonville (A.V.), and Florida Hospital Cancer Institute, Orlando (T.M.) - all in Florida; Tennessee Oncology, Chattanooga, and Sarah Cannon Research Institute, Nashville - both in Tennessee (D.D.); Hospital Universitario Virgen Macarena, Seville (D.V.), and Hospital Universitario 12 de Octubre, Centro de Investigación Biomédica en Red de Cáncer, Universidad Complutense and the Spanish National Cancer Research Center (L.P.-A.), and Hospital Universitario La Paz (J.C.C.), Madrid - all in Spain; Kanagawa Cancer Center, Yokohama (S.M.), Kansai Medical University Hospital, Hirakata (T.Y.), Kurume University Hospital, Kurume (T.T.), and Nippon Medical School Hospital, Tokyo (K.K.) - all in Japan; Westmead Hospital and the University of Sydney, Sydney (R.H.), and Flinders University and Flinders Medical Centre, Bedford Park, SA (C.S.K.) - all in Australia; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.), Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju (Y.-C.K.) - all in South Korea; Vivantes Klinikum Neukölln, Berlin (M.W.); Centre Hospitalier Universitaire de Liège, Liège, Belgium (M.B.); Centre Hospitalier Universitaire Montpellier and Cancer Institute of Montpellier Val d'Aurelle, Montpellier (X.Q.), Institut Gustave Roussy, Villejuif (D.P.), and Institut de Cancérologie de l'Ouest-Site René Gauducheau, Saint Herblain (S.H.) - all in France; National Koranyi Institute of Pulmonology, Budapest, Hungary (G.O.); AstraZeneca, Alderley Park, United Kingdom (C.W.); AstraZeneca, Gaithersburg, MD (G.M., H.J., Y.H., P.A.D.); and Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey (M.Ö.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709937DOI Listing
November 2017

Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer.

Asia Pac J Clin Oncol 2017 Aug 12;13(4):296-303. Epub 2017 Jul 12.

Flinders Medical Centre and Flinders University, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12699DOI Listing
August 2017

Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.

Intern Med J 2017 Apr;47(4):408-414

Department of Psychological Sciences, School of Health Sciences, Swinburne University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13373DOI Listing
April 2017

Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.

Acta Oncol 2016 15;55(4):480-5. Epub 2016 Feb 15.

a Department of Medical Oncology , The Queen Elizabeth Hospital & University of Adelaide , Adelaide , SA , Australia ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1117135DOI Listing
December 2016

Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.

J Clin Oncol 2016 07 25;34(19):2258-64. Epub 2016 Apr 25.

Eva Segelov, St Vincent's Clinical School, University of New South Wales; Subotheni Thavaneswaran, Kristy P. Robledo, Val J. Gebski, Mustafa Khasraw, Kate Wilson, and John Simes, National Health and Medical Research Council Clinical Trials Centre (NHMRC), University of Sydney; Lorraine A. Chantrill, Macarthur Cancer Therapy Centre, Campbelltown Hospital and Kinghorn Cancer Centre; Nick Pavlakis and Mustafa Khasraw, Royal North Shore Hospital University of Sydney, Sydney; Paul M. Waring and Sebastian Lunke, Centre for Translational Pathology, University of Melbourne; Jayesh Desai, Royal Melbourne Hospital; Jayesh Desai and Michael Jefford, Peter MacCallum Cancer Centre; Andrew Haydon, Alfred Hospital; Jeremy D. Shapiro, Cabrini Hospital, Melbourne; Louise M. Nott, Royal Hobart Hospital, Hobart; Christos S. Karapetis, Flinders University and Flinders Medical Centre; Timothy J. Price, Queen Elizabeth Hospital and Lyell McEwin Hospital, Adelaide; Craig Underhill, Border Medical Oncology, Albury-Wodonga; Guy van Hazel, Sir Charles Gairdner Hospital, Perth, Australia; Elena Elez, Vall d'Hebron University Hospital, Barcelona, Spain; Fortunato Ciardiello, Seconda Università degli Studi di Napoli, Naples, Italy; and Harpreet Wasan, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.6843DOI Listing
July 2016

RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer.

Clin Colorectal Cancer 2016 06 11;15(2):95-103. Epub 2015 Nov 11.

Flinders University, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Adelaide, South Australia, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.10.006DOI Listing
June 2016

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

Clin Cancer Res 2016 05;22(10):2435-44

Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0414DOI Listing
May 2016

Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.

Expert Rev Mol Diagn 2015 12;15(8):1033-48. Epub 2015 Jul 12.

Flinders Medical Centre, Sturt Road, Bedford Park, South Australia 5042, Australia.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737159.2015.10
Publisher Site
http://dx.doi.org/10.1586/14737159.2015.1052797DOI Listing
April 2016

Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry.

Clin Colorectal Cancer 2016 Mar 30;15(1):32-6. Epub 2015 Jul 30.

Department of Medical Oncology, Flinders Medical Centre, Adelaide, South Australia, Australia; Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.07.005DOI Listing
March 2016

Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.

Eur J Cancer 2016 Mar 23;55:122-30. Epub 2016 Jan 23.

Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, 5042, Australia; Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, 5042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.11.025DOI Listing
March 2016

Colorectal cancer treatment and survival: the experience of major public hospitals in south Australia over three decades.

Asian Pac J Cancer Prev 2015 ;16(6):2431-40

School of Population Health, University of South Australia, Adelaide, South Australia E-mail :

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7314/apjcp.2015.16.6.2431DOI Listing
February 2016

Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small-cell lung cancer: an open-label phase II multicentre trial (COVeRT study).

Anticancer Drugs 2015 Nov;26(10):1083-8

aDepartment of Medical Oncology, University of Adelaide bDepartment of Radiation Oncology, Royal Adelaide Hospital, North Terrace Adelaide cDepartment of Medical Oncology, The Queen Elizabeth Hospital, Woodville South dFlinders Centre for Innovation in Cancer, Flinders University eFlinders Centre for Epidemiology and Biostatistics, School of Medicine, Flinders University, Bedford Park, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000291DOI Listing
November 2015

Colorectal cancer: Metastases to a single organ.

World J Gastroenterol 2015 Nov;21(41):11767-76

Sina Vatandoust, Christos S Karapetis, Department of Medical Oncology, Flinders Medical Centre, Adelaide, SA 5042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i41.11767DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631975PMC
November 2015

Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study.

Support Care Cancer 2015 May 16;23(5):1233-6. Epub 2014 Oct 16.

Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Level 5 Medical School North, Frome Road, Adelaide, South Australia, 5005, Australia,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2481-zDOI Listing
May 2015

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.

Expert Rev Anticancer Ther 2014 Dec 20;14(12):1477-93. Epub 2014 Aug 20.

The Queen Elizabeth Hospital, Adelaide Colorectal Tumour Group and University of Adelaide, Adeaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.949678DOI Listing
December 2014

Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer.

Clin Colorectal Cancer 2014 Sep 23;13(3):156-163.e2. Epub 2014 Jun 23.

Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2014.04.001DOI Listing
September 2014

Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.

Clin Colorectal Cancer 2014 Jun 13;13(2):87-93. Epub 2013 Nov 13.

Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Flinders Medical Centre, Bedford Park, Australia; Flinders Centre for Innovation in Cancer, Flinders University, Bedford Park, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2013.11.008DOI Listing
June 2014

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Clin Cancer Res 2014 Feb 11;20(3):744-53. Epub 2013 Nov 11.

Authors' Affiliation: Flinders University, Flinders Centre for Innovation in Cancer; Department of Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0606DOI Listing
February 2014

Personalized treatment for advanced colorectal cancer: KRAS and beyond.

Cancer Manag Res 2013 21;5:387-400. Epub 2013 Nov 21.

Department of Medical Oncology, Flinders Medical Centre, Flinders University, Bedford Park, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CMAR.S35025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839845PMC
December 2013

Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy.

Acta Oncol 2013 Nov;52(8):1699-706

Department of Medical Oncology, The Queen Elizabeth Hospital and University of Adelaide , South Australia , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2013.831473DOI Listing
November 2013

Current opinion on optimal treatment for colorectal cancer.

Expert Rev Anticancer Ther 2013 May;13(5):597-611

The Queen Elizabeth Hospital, Adelaide Colorectal Tumour Group and University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.13.37DOI Listing
May 2013

Rechallenge with oxaliplatin and fluoropyrimidine for metastatic colorectal carcinoma after prior therapy.

Am J Clin Oncol 2013 Feb;36(1):49-52

Department of Haematology-Oncology, The Queen Elizabeth Hospital, Woodville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31823fe40eDOI Listing
February 2013

Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.

Crit Rev Oncol Hematol 2013 Feb 2;85(2):121-35. Epub 2012 Jul 2.

Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2012.06.001DOI Listing
February 2013

Targeted therapy for esophagogastric cancers: a review.

Onco Targets Ther 2012 21;5:91-102. Epub 2012 May 21.

Flinders Medical Centre, Adelaide, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S25117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377432PMC
October 2012

Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer.

Eur J Cancer 2012 Jun 24;48(9):1293-8. Epub 2011 Nov 24.

Department Medical Oncology, The Queen Elizabeth Hospital, Woodville Rd, Woodville, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2011.09.029DOI Listing
June 2012

Management of advanced gastric cancer.

Expert Rev Gastroenterol Hepatol 2012 Apr;6(2):199-208; quiz 209

Haematology Oncology Unit, The Queen Elizabeth Hospital, Woodville Rd, Woodville, SA 5011, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/egh.11.103DOI Listing
April 2012

"Watchful waiting" for metastatic colorectal cancer, antediluvian or an option to be considered again?

Asia Pac J Clin Oncol 2012 Mar;8(1):10-3

Haematology-Oncology Department, The Queen Elizabeth Hospital, Woodville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2011.01458.xDOI Listing
March 2012

Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.

Clin Exp Gastroenterol 2009 24;2:75-83. Epub 2009 Jul 24.

Flinders University Department of Surgery, Flinders Medical Centre, Bedford Park, South Australia, Australia;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108630PMC
http://dx.doi.org/10.2147/ceg.s6273DOI Listing
July 2011